Clinical trials
Terminated Phase 1 Fallopian Tube Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abramson Cancer Center at Penn Medicine | 2 |
| Gynecologic Oncology Group | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| ADC Therapeutics S.A. | 1 |
| Brown University | 1 |
| Celgene | 1 |
| Dana-Farber Cancer Institute | 1 |
| Hoffmann-La Roche | 1 |
| Instil Bio | 1 |
| Kite, A Gilead Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fallopian Tube Neoplasms | 30 |
| Ovarian Neoplasms | 27 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Carcinoma, Ovarian Epithelial | 8 |
| Triple Negative Breast Neoplasms | 6 |
| Carcinoma, Renal Cell | 5 |
| Endometrial Neoplasms | 5 |
| Melanoma | 3 |
| Neoplasms | 3 |
| Stomach Neoplasms | 3 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.